Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-nave patients with type 2 diabetes (SUSTAIN 4): a randomized, open-label, parallel-group, multicentre, multinational, phase 3a trial
Administered once a week, the dosage of Semaglutide is carefully increased over time to minimize side effects and maximize effectiveness
doi:10.1042/bj2750171
Which products should we notify you about
March 4: Turn that frown upside down
US$ 27.74
US$ 29.80
US$ 22.87
